These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17079749)

  • 1. Invited commentary.
    Beaton D
    Phys Ther; 2006 Nov; 86(11):1496-8; author reply 1498-1500. PubMed ID: 17079749
    [No Abstract]   [Full Text] [Related]  

  • 2. OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis.
    Gossec L; Hawker G; Davis AM; Maillefert JF; Lohmander LS; Altman R; Cibere J; Conaghan PG; Hochberg MC; Jordan JM; Katz JN; March L; Mahomed N; Pavelka K; Roos EM; Suarez-Almazor ME; Zanoli G; Dougados M
    J Rheumatol; 2007 Jun; 34(6):1432-5. PubMed ID: 17552070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity and internal consistency of a Yoruba version of the Ibadan knee/hip osteoathritis outcome measure (Yoruba IKHOAM).
    Odole AC; Akinpelu AO; Bamgboye EA
    Afr J Med Med Sci; 2006 Sep; 35(3):349-57. PubMed ID: 17312744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of aquatic exercise on flexibility, strength and aerobic fitness in adults with osteoarthritis of the hip or knee.
    Wang TJ; Belza B; Elaine Thompson F; Whitney JD; Bennett K
    J Adv Nurs; 2007 Jan; 57(2):141-52. PubMed ID: 17214750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arthroscopic surgery for osteoarthritis of the knee.
    Chambers KG; Schulzer M
    N Engl J Med; 2002 Nov; 347(21):1717-9; author reply 1717-9. PubMed ID: 12448431
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in outcome measures for impairment, activity limitation, and participation restriction over two years in osteoarthritis of the lower extremities.
    Botha-Scheepers S; Watt I; Rosendaal FR; Breedveld FC; Hellio le Graverand MP; Kloppenburg M
    Arthritis Rheum; 2008 Dec; 59(12):1750-5. PubMed ID: 19035428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for functional decline in osteoarthritis of the hip or knee.
    Dekker J; van Dijk GM; Veenhof C
    Curr Opin Rheumatol; 2009 Sep; 21(5):520-4. PubMed ID: 19550331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons learned from nine clinical trials of disease-modifying osteoarthritis drugs.
    Brandt KD; Mazzuca SA
    Arthritis Rheum; 2005 Nov; 52(11):3349-59. PubMed ID: 16258927
    [No Abstract]   [Full Text] [Related]  

  • 9. Pain and rheumatology: thinking outside the joint.
    Clauw DJ; Witter J
    Arthritis Rheum; 2009 Feb; 60(2):321-4. PubMed ID: 19180503
    [No Abstract]   [Full Text] [Related]  

  • 10. Pain, physical functioning and quality of life of individuals awaiting total joint replacement: a longitudinal study.
    McHugh GA; Luker KA; Campbell M; Kay PR; Silman AJ
    J Eval Clin Pract; 2008 Feb; 14(1):19-26. PubMed ID: 18211639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of foot and ankle assessment of patients with lower limb osteoarthritis.
    Reilly K; Barker K; Shamley D; Newman M; Oskrochi GR; Sandall S
    Physiotherapy; 2009 Sep; 95(3):164-9. PubMed ID: 19635335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, multicentre, double-blind, parallel-group study to assess the adverse event-related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis.
    Dahlberg LE; Holme I; Høye K; Ringertz B
    Scand J Rheumatol; 2009; 38(2):133-43. PubMed ID: 19165648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety, and tolerability of the cyclooxygenase-inhibiting nitric oxide donator naproxcinod in treating osteoarthritis of the hip or knee.
    Karlsson J; Pivodic A; Aguirre D; Schnitzer TJ
    J Rheumatol; 2009 Jun; 36(6):1290-7. PubMed ID: 19411388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the progression of osteoarthritis phasic? Evidence and implications.
    Kirwan JR; Elson CJ
    J Rheumatol; 2000 Apr; 27(4):834-6. PubMed ID: 10782803
    [No Abstract]   [Full Text] [Related]  

  • 15. New study design evaluated the validity of measures to assess change after hip or knee arthroplasty.
    Stratford PW; Kennedy DM; Riddle DL
    J Clin Epidemiol; 2009 Mar; 62(3):347-52. PubMed ID: 18834709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and burden of osteoarthritis: results from a population survey in Norway.
    Grotle M; Hagen KB; Natvig B; Dahl FA; Kvien TK
    J Rheumatol; 2008 Apr; 35(4):677-84. PubMed ID: 18278832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chondroitin sulfate in the management of hip and knee osteoarthritis: an overview.
    Bana G; Jamard B; Verrouil E; Mazières B
    Adv Pharmacol; 2006; 53():507-22. PubMed ID: 17239784
    [No Abstract]   [Full Text] [Related]  

  • 18. Individualising the Western Ontario and McMaster Universities osteoarthritis index (WOMAC) function subscale: incorporating patient priorities for improvement to measure functional impairment in hip or knee osteoarthritis.
    Seror R; Tubach F; Baron G; Falissard B; Logeart I; Dougados M; Ravaud P
    Ann Rheum Dis; 2008 Apr; 67(4):494-9. PubMed ID: 17704063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting self-reported pain and physical function in patients with hip osteoarthritis.
    Juhakoski R; Tenhonen S; Anttonen T; Kauppinen T; Arokoski JP
    Arch Phys Med Rehabil; 2008 Jun; 89(6):1066-73. PubMed ID: 18503801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The measurement of joint mechanics and their role in osteoarthritis genesis and progression.
    Wilson DR; McWalter EJ; Johnston JD
    Med Clin North Am; 2009 Jan; 93(1):67-82, x. PubMed ID: 19059022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.